U.S., Feb. 4 -- ClinicalTrials.gov registry received information related to the study (NCT07383571) titled 'Oral Hyoscine vs. Topical EMLA vs. Placebo for Pain Reduction During Hysterosalpingography' on Sept. 21, 2025.
Brief Summary: This randomized, double-blind, placebo-controlled, will evaluate whether oral hyoscine butylbromide or topical eutectic lidocaine-prilocaine (EMLA) spray reduces pain during hysterosalpingography (HSG) compared with placebo
Study Start Date: Oct. 03, 2025
Study Type: INTERVENTIONAL
Condition:
Hysterosalpingography
Intervention:
DRUG: Oral Hyoscine butylbromide and Placebo Spray
Hyoscine butylbromide 20 mg oral tablet, single dose 30 min before HSG PLUS placebo cervical spray
DRUG: Topical EMLA Spray an...